Pages that link to "Q70648915"

The following pages link to Cis-diamminedichloride platinum II in the treatment of advanced bladder cancer (Q70648915):

Displaying 22 items.

• Evidence for a schedule-dependent deleterious interaction between paclitaxel, vinblastine and cisplatin (PVC) in the treatment of advanced transitional cell carcinoma (Q28344992) (← links)
• Systemic, perioperative management of muscle-invasive bladder cancer and future horizons (Q30240816) (← links)
• Cisplatin as adjunctive treatment for invasive bladder carcinoma: tolerance and toxicities. (Q33479138) (← links)
• Early clinical studies with cis-diammine-1,1-cyclobutane dicarboxylate platinum II. (Q33481362) (← links)
• Preliminary results of concurrent methotrexate, cisplatin and radiation treatment for locally advanced urothelial cancers (Q33497086) (← links)
• Gemcitabine/paclitaxel-based three-drug regimens in advanced urothelial cancer (Q33978846) (← links)
• Chemotherapy of advanced transitional-cell carcinoma of the bladder (Q35370321) (← links)
• Phase II study of pemetrexed in combination with cisplatin in patients with advanced urothelial cancer: the PECULIAR study (KCSG 10-17). (Q35677288) (← links)
• Results of systemic chemotherapy of advanced bladder carcinomas (phase II study). (Q39303616) (← links)
• Landmarks in the treatment of muscle-invasive bladder cancer (Q39413207) (← links)
• Chemotherapy of advanced transitional cell carcinoma of the uroepithelium (Q40162823) (← links)
• Progress in chemotherapy for cancers of the urothelium (Q40173848) (← links)
• Cooperative studies of systemic chemotherapy. A review of the work of the EORTC Urological Group and of the Yorkshire Urological Cancer Research Group (YUCRG). (Q40209625) (← links)
• Metastatic bladder cancer: advances in treatment (Q41483381) (← links)
• Systemic chemotherapy of transitional cell carcinoma of the urothelium (Q41564562) (← links)
• Cisplatin-based chemotherapy for the treatment of advanced transitional-cell carcinoma of the urinary tract--a preliminary report (Q67552759) (← links)
• Methotrexate, vinblastine, epidoxorubicin and cisplatin (M-VEC) in patients with locally advanced transitional bladder cancer (Q67776576) (← links)
• Effects of single chemotherapeutic agents on development of urinary bladder tumor induced by N-butyl-N-(4-hydroxybutyl) nitrosamine (BBN) in rats (Q68550854) (← links)
• Adjuvant chemotherapy for invasive bladder cancer (Q70362710) (← links)
• Carboplatin-based versus cisplatin-based chemotherapy in the treatment of surgically incurable advanced bladder carcinoma (Q73872746) (← links)
• [Conservative treatment of bladder cancers with radiotherapy and concurrent chemotherapy: results and perspectives] (Q77734739) (← links)
• [Advanced bladder cancer: new therapeutic strategies] (Q78898958) (← links)